(2S)-2-[[(1S,4S,10S,13S,19S,22S,25S,29R,30S,33S,44R)-30-[[(2S)-1,3-dihydroxy-2-[[(2S)-1-hydroxy-2-(1-hydroxyethylideneamino)-3-(4-hydroxyphenyl)propylidene]amino]propylidene]amino]-2,11,21,24,31,34,41,47-octahydroxy-4-[(4-hydroxyphenyl)methyl]-22-(1H-indol-3-ylmethyl)-29-methyl-33-(2-methylpropyl)-5,16,27,45-tetraoxo-15,28-dioxa-3,6,12,20,23,32,35,40,46-nonazatetracyclo[17.16.10.213,25.06,10]heptatetraconta-2,11,20,23,31,34,40,46-octaen-44-yl]amino]-3-(4-hydroxyphenyl)propanoic acid

Details

Top
Internal ID 09c3a90b-c53d-4a65-a814-15e5257e390c
Taxonomy Organic acids and derivatives > Peptidomimetics > Hybrid peptides
IUPAC Name (2S)-2-[[(1S,4S,10S,13S,19S,22S,25S,29R,30S,33S,44R)-30-[[(2S)-1,3-dihydroxy-2-[[(2S)-1-hydroxy-2-(1-hydroxyethylideneamino)-3-(4-hydroxyphenyl)propylidene]amino]propylidene]amino]-2,11,21,24,31,34,41,47-octahydroxy-4-[(4-hydroxyphenyl)methyl]-22-(1H-indol-3-ylmethyl)-29-methyl-33-(2-methylpropyl)-5,16,27,45-tetraoxo-15,28-dioxa-3,6,12,20,23,32,35,40,46-nonazatetracyclo[17.16.10.213,25.06,10]heptatetraconta-2,11,20,23,31,34,40,46-octaen-44-yl]amino]-3-(4-hydroxyphenyl)propanoic acid
SMILES (Canonical) CC1C(C(=NC(C(=NC2CCCCN=C(CCC(C(=O)C3CCC(=O)OCC(C(=NC(CC(=O)O1)C(=NC(C(=N3)O)CC4=CNC5=CC=CC=C54)O)O)N=C(C6CCCN6C(=O)C(N=C2O)CC7=CC=C(C=C7)O)O)NC(CC8=CC=C(C=C8)O)C(=O)O)O)O)CC(C)C)O)N=C(C(CO)N=C(C(CC9=CC=C(C=C9)O)N=C(C)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H](C(=N[C@H](C(=N[C@H]2CCCCN=C(CC[C@H](C(=O)[C@@H]3CCC(=O)OC[C@@H](C(=N[C@@H](CC(=O)O1)C(=N[C@H](C(=N3)O)CC4=CNC5=CC=CC=C54)O)O)N=C([C@@H]6CCCN6C(=O)[C@@H](N=C2O)CC7=CC=C(C=C7)O)O)N[C@@H](CC8=CC=C(C=C8)O)C(=O)O)O)O)CC(C)C)O)N=C([C@H](CO)N=C([C@H](CC9=CC=C(C=C9)O)N=C(C)O)O)O
InChI InChI=1S/C80H100N14O23/c1-41(2)32-56-71(105)86-55-12-7-8-30-81-65(100)28-26-53(84-61(80(114)115)35-46-18-24-50(99)25-19-46)69(103)54-27-29-66(101)116-40-63(92-77(111)64-13-9-31-94(64)79(113)60(90-70(55)104)34-45-16-22-49(98)23-17-45)76(110)88-59(74(108)87-58(73(107)85-54)36-47-38-82-52-11-6-5-10-51(47)52)37-67(102)117-42(3)68(78(112)89-56)93-75(109)62(39-95)91-72(106)57(83-43(4)96)33-44-14-20-48(97)21-15-44/h5-6,10-11,14-25,38,41-42,53-64,68,82,84,95,97-99H,7-9,12-13,26-37,39-40H2,1-4H3,(H,81,100)(H,83,96)(H,85,107)(H,86,105)(H,87,108)(H,88,110)(H,89,112)(H,90,104)(H,91,106)(H,92,111)(H,93,109)(H,114,115)/t42-,53-,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,68+/m1/s1
InChI Key NFNSLVJFCIPOAU-SOBUNMMOSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C80H100N14O23
Molecular Weight 1625.70 g/mol
Exact Mass 1624.70857549 g/mol
Topological Polar Surface Area (TPSA) 595.00 Ų
XlogP 3.20
Atomic LogP (AlogP) 7.43
H-Bond Acceptor 23
H-Bond Donor 18
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S)-2-[[(1S,4S,10S,13S,19S,22S,25S,29R,30S,33S,44R)-30-[[(2S)-1,3-dihydroxy-2-[[(2S)-1-hydroxy-2-(1-hydroxyethylideneamino)-3-(4-hydroxyphenyl)propylidene]amino]propylidene]amino]-2,11,21,24,31,34,41,47-octahydroxy-4-[(4-hydroxyphenyl)methyl]-22-(1H-indol-3-ylmethyl)-29-methyl-33-(2-methylpropyl)-5,16,27,45-tetraoxo-15,28-dioxa-3,6,12,20,23,32,35,40,46-nonazatetracyclo[17.16.10.213,25.06,10]heptatetraconta-2,11,20,23,31,34,40,46-octaen-44-yl]amino]-3-(4-hydroxyphenyl)propanoic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6723 67.23%
Caco-2 - 0.8584 85.84%
Blood Brain Barrier - 0.9500 95.00%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Nucleus 0.3803 38.03%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8067 80.67%
OATP1B3 inhibitior + 0.9240 92.40%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8000 80.00%
BSEP inhibitior + 0.9797 97.97%
P-glycoprotein inhibitior + 0.7421 74.21%
P-glycoprotein substrate + 0.8580 85.80%
CYP3A4 substrate + 0.7593 75.93%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8057 80.57%
CYP3A4 inhibition - 0.6854 68.54%
CYP2C9 inhibition - 0.8713 87.13%
CYP2C19 inhibition - 0.8481 84.81%
CYP2D6 inhibition - 0.8516 85.16%
CYP1A2 inhibition - 0.9288 92.88%
CYP2C8 inhibition + 0.8461 84.61%
CYP inhibitory promiscuity - 0.7399 73.99%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.6042 60.42%
Eye corrosion - 0.9877 98.77%
Eye irritation - 0.8957 89.57%
Skin irritation - 0.7850 78.50%
Skin corrosion - 0.9336 93.36%
Ames mutagenesis - 0.5428 54.28%
Human Ether-a-go-go-Related Gene inhibition + 0.7064 70.64%
Micronuclear + 0.7900 79.00%
Hepatotoxicity - 0.5270 52.70%
skin sensitisation - 0.8733 87.33%
Respiratory toxicity + 0.8000 80.00%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.9000 90.00%
Nephrotoxicity - 0.8184 81.84%
Acute Oral Toxicity (c) III 0.5744 57.44%
Estrogen receptor binding - 0.5131 51.31%
Androgen receptor binding + 0.7698 76.98%
Thyroid receptor binding + 0.8062 80.62%
Glucocorticoid receptor binding + 0.8378 83.78%
Aromatase binding + 0.7696 76.96%
PPAR gamma + 0.8021 80.21%
Honey bee toxicity - 0.6290 62.90%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9226 92.26%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 99.97% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 99.70% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.34% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 97.54% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 96.93% 94.45%
CHEMBL2693 Q9UIQ6 Cystinyl aminopeptidase 95.99% 97.64%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 95.34% 85.14%
CHEMBL5103 Q969S8 Histone deacetylase 10 94.41% 90.08%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.73% 96.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 93.72% 95.89%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 93.70% 99.23%
CHEMBL1293249 Q13887 Kruppel-like factor 5 93.44% 86.33%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.88% 89.00%
CHEMBL2535 P11166 Glucose transporter 92.88% 98.75%
CHEMBL4040 P28482 MAP kinase ERK2 91.15% 83.82%
CHEMBL3310 Q96DB2 Histone deacetylase 11 89.71% 88.56%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 88.44% 91.71%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 88.01% 95.71%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 87.39% 93.10%
CHEMBL3137262 O60341 LSD1/CoREST complex 86.84% 97.09%
CHEMBL5043 Q6P179 Endoplasmic reticulum aminopeptidase 2 85.56% 91.81%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 83.94% 100.00%
CHEMBL2803 P43403 Tyrosine-protein kinase ZAP-70 83.68% 82.50%
CHEMBL3837 P07711 Cathepsin L 83.15% 96.61%
CHEMBL5805 Q9NR97 Toll-like receptor 8 83.08% 96.25%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.94% 99.17%
CHEMBL1255126 O15151 Protein Mdm4 82.86% 90.20%
CHEMBL5966 P55899 IgG receptor FcRn large subunit p51 82.84% 90.93%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.36% 90.71%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 81.88% 93.00%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.44% 92.62%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 81.40% 97.14%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 81.38% 95.83%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 80.30% 94.00%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 80.18% 96.47%
CHEMBL4523377 Q86WV6 Stimulator of interferon genes protein 80.04% 95.48%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 146683627
LOTUS LTS0019104
wikiData Q104203124